Diego O. Andrey

1.9k total citations
52 papers, 1.1k citations indexed

About

Diego O. Andrey is a scholar working on Infectious Diseases, Molecular Medicine and Molecular Biology. According to data from OpenAlex, Diego O. Andrey has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 20 papers in Molecular Medicine and 15 papers in Molecular Biology. Recurrent topics in Diego O. Andrey's work include Antibiotic Resistance in Bacteria (20 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Diego O. Andrey is often cited by papers focused on Antibiotic Resistance in Bacteria (20 papers), Antimicrobial Resistance in Staphylococcus (12 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Diego O. Andrey collaborates with scholars based in Switzerland, United States and United Kingdom. Diego O. Andrey's co-authors include William L. Kelley, Antoinette Monod, Adriana Renzoni, Laurent Kaiser, Ambre Jousselin, Ambrose L. Cheung, Roberto Sierra, Mélanie Roch, Timothy R. Walsh and Nicolas Vuilleumier and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

Diego O. Andrey

48 papers receiving 1.1k citations

Peers

Diego O. Andrey
Diego O. Andrey
Citations per year, relative to Diego O. Andrey Diego O. Andrey (= 1×) peers Kotaro Aoki

Countries citing papers authored by Diego O. Andrey

Since Specialization
Citations

This map shows the geographic impact of Diego O. Andrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego O. Andrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego O. Andrey more than expected).

Fields of papers citing papers by Diego O. Andrey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diego O. Andrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego O. Andrey. The network helps show where Diego O. Andrey may publish in the future.

Co-authorship network of co-authors of Diego O. Andrey

This figure shows the co-authorship network connecting the top 25 collaborators of Diego O. Andrey. A scholar is included among the top collaborators of Diego O. Andrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diego O. Andrey. Diego O. Andrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Najjar, I.M.R., Ikechukwu Benjamin Moses, Mélanie Roch, et al.. (2025). Phage therapy for KPC-producing Klebsiella pneumoniae decolonization in high-risk patients: The KIDNAP Study Protocol – A prospective feasibility and proof of concept study in the Brazilian context. International Journal of Antimicrobial Agents. 67(1). 107673–107673.
2.
Qamar, Muhammad Usman, et al.. (2025). Genomic characterization of plasmids harboring bla NDM-1, bla NDM-5, and bla NDM-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan. Microbiology Spectrum. 13(7). e0235924–e0235924. 1 indexed citations
3.
Sierra, Roberto, Mélanie Roch, Julien Prados, et al.. (2025). Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas. Journal of Antimicrobial Chemotherapy. 80(10). 2876–2879. 1 indexed citations
4.
Roch, Mélanie, Roberto Sierra, Gaël Panis, Willames M. B. S. Martins, & Diego O. Andrey. (2025). Synergistic activity of a KL51-depolymerase and a Sugarlandvirus bacteriophage against ST16 Klebsiella pneumoniae. Microbiology Spectrum. 13(12). e0214225–e0214225.
5.
Sierra, Roberto, Mélanie Roch, Julien Prados, et al.. (2024). Contributions of Long-Read Sequencing for the Detection of Antimicrobial Resistance. Pathogens. 13(9). 730–730. 2 indexed citations
6.
Zheng, Mei, Juan Liu, Wenjie Li, et al.. (2024). Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae. Journal of Antimicrobial Chemotherapy. 79(5). 1069–1080. 1 indexed citations
7.
Pham, Truong‐Thanh, Diego O. Andrey, Susanne Stampf, et al.. (2022). Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients. American Journal of Transplantation. 22(12). 3031–3046. 5 indexed citations
8.
Martins, Willames M. B. S., Diego O. Andrey, Qiu E. Yang, et al.. (2022). Silent circulation of BKC-1-producing Klebsiella pneumoniae ST442: molecular and clinical characterization of an early and unreported outbreak. International Journal of Antimicrobial Agents. 59(5). 106568–106568. 1 indexed citations
9.
Abbas, Mohamed, Nadia Gaïa, Nicolas C. Buchs, et al.. (2022). Changes in the gut bacterial communities in colon cancer surgery patients: an observational study. Gut Pathogens. 14(1). 2–2. 6 indexed citations
10.
Lauper, Kim, Gautier Bréville, Rachel Goldstein, et al.. (2021). Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study. Clinical Infectious Diseases. 75(1). e1037–e1045. 73 indexed citations
11.
Swank, Zoe, Diego O. Andrey, Nicolas Vuilleumier, et al.. (2021). A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples. Proceedings of the National Academy of Sciences. 118(18). 48 indexed citations
12.
Vetter, Pauline, Samuel Cordey, Manuel Schibler, et al.. (2021). Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfection. Clinical Microbiology and Infection. 27(5). 791.e1–791.e4. 15 indexed citations
13.
Perez‐Saez, Javier, María‐Eugenia Zaballa, Sabine Yerly, et al.. (2021). Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance. Clinical Microbiology and Infection. 27(11). 1695.e7–1695.e12. 25 indexed citations
14.
Yang, Qiu E., R. Craig MacLean, Andrei Papkou, et al.. (2020). Compensatory mutations modulate the competitiveness and dynamics of plasmid-mediated colistin resistance in Escherichia coli clones. The ISME Journal. 14(3). 861–865. 43 indexed citations
15.
Sierra, Roberto, Julien Prados, Olesya O. Panasenko, et al.. (2020). Insights into the global effect on Staphylococcus aureus growth arrest by induction of the endoribonuclease MazF toxin. Nucleic Acids Research. 48(15). 8545–8561. 13 indexed citations
16.
L’Huillier, Arnaud G., Benjamin Meyer, Diego O. Andrey, et al.. (2020). Antibody Persistence in the Six Months Following SARS-CoV-2 Infection Among Hospital Workers. SSRN Electronic Journal. 2 indexed citations
17.
Andrey, Diego O., Tristan Ferry, Nils Siegenthaler, et al.. (2015). Unusual staphylococcal toxic shock syndrome presenting as a scarlet-like fever. New Microbes and New Infections. 8. 10–13.
18.
Jousselin, Ambre, Adriana Renzoni, Diego O. Andrey, et al.. (2012). The Posttranslocational Chaperone Lipoprotein PrsA Is Involved in both Glycopeptide and Oxacillin Resistance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 56(7). 3629–3640. 54 indexed citations
19.
Renzoni, Adriana, Diego O. Andrey, Ambre Jousselin, et al.. (2011). Whole Genome Sequencing and Complete Genetic Analysis Reveals Novel Pathways to Glycopeptide Resistance in Staphylococcus aureus. PLoS ONE. 6(6). e21577–e21577. 60 indexed citations
20.
Uçkay, İlker, Tristan Ferry, Richard Stern, et al.. (2009). Use of serum antistreptolysin O titers in the microbial diagnosis of orthopedic infections. International Journal of Infectious Diseases. 13(4). 421–424. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026